Ventaris Surgical, Inc. Announces $30M Series A to Advance a Next-Generation System for Complete Kidney Stone Treatment [Yahoo! Finance]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Yahoo! Finance
system for kidney stone treatment, announced today the completion of a $30 million Series A financing. The financing was led by Longitude Capital, with additional participation from new investor Vensana Capital and existing investors Atypical Ventures, Neotribe Ventures, and Boutique Venture Partners. As part of this financing, Varun Gupta of Longitude Capital and Justin Klein of Vensana Capital will join the Ventaris Board of Directors, alongside independent board member Amir Abolfathi. Ventaris Surgical is developing a ureteroscopic system designed to help surgeons achieve more complete stone clearance during kidney stone procedures. Kidney stone surgery is among the most common urologic interventions, yet procedural success is influenced by a complex set of variables including anatomy, stone burden, workflow constraints, and surgeon fatigue. This makes consistent, complete stone clearance difficult to achieve with today's tools. "Ventaris' technology has the potential to both
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- Boston Scientific Announces Agreement to Acquire Valencia Technologies Corporation [Yahoo! Finance]Yahoo! Finance
- Boston Scientific Announces Agreement to Acquire Valencia Technologies CorporationPR Newswire
- Venous Stents Market Size to Reach USD 2.57 Billion by 2033, Driven by Rising Chronic Venous Disease Burden – SNS Insider [Yahoo! Finance]Yahoo! Finance
- A Look At Boston Scientific (BSX) Valuation As Analyst Optimism And Earnings Anticipation Build [Yahoo! Finance]Yahoo! Finance
- Did Analyst Upgrades and Pipeline Optimism Just Shift Boston Scientific's (BSX) Investment Narrative? [Yahoo! Finance]Yahoo! Finance
BSX
Earnings
- 10/22/25 - Beat
BSX
Sec Filings
- 12/8/25 - Form 3
- 12/2/25 - Form 4
- 12/1/25 - Form 4
- BSX's page on the SEC website